Maya Romanchuk

Maya Romanchuk is a Senior Account Executive at LifeSci Communications where she provides strategic support and oversees day-to-day activities for a wide range of biotechnology companies spanning various therapeutic areas and stages of clinical development, with a focus on pre-commercial and commercial entities.

Maya specializes in developing and executing corporate communications programs and materials that drive high-profile visibility to key external stakeholders, including industry peers, investors, healthcare professionals, patients, advocacy organizations, and potential partners.

She leverages her expertise in crafting corporate and scientific messaging, providing support for digital campaigns, and executing strategic media relations initiatives to bolster pivotal company milestones – ranging from FDA approval, product launch and commercialization, clinical data readouts and publications, global strategic partnerships, financing rounds, and more.

Prior to joining LifeSci Communications, Maya interned at Amicus Therapeutics where she gained a broad scope of relevant experience working for both the Global Marketing Team as well as the Patient & Professional Advocacy Team. As a Global Marketing Intern, she worked with HCP Educational and Promotional material to optimize Amicus’ position in the market. As a Patient & Professional Advocacy Intern, she gained valuable experience within the rare disease community working directly with Fabry patients, piloting the company’s very first Fabry Patient Advisory Board. She also conducted a comprehensive competitive analysis of the Gene Therapy Landscape, identifying key differentiators among rare disease organizations involved in gene therapy.

Maya holds a Bachelor of Science degree in Health Administration from the Edward J. Bloustein School of Planning and Public Policy at Rutgers University New Brunswick.